[The role of stomach epithelial cells being immunopositive for NO synthase in the formation of chronic cholecystitis].
The article provides information on 145 patients with chronic acalculous cholecystitis and 62 patients with chronic calculous cholecystitis subjected to a study of the quantitative characteristic of gastric antral epithelial cells immunopositive for NO synthase. The increased number of NO synthase immunopositive gastric epithelial cells at chronic cholecystitis was discovered. Most of them were discovered at the calculous process. The study discovered the relation between the gallbladder inflammatory activity, bile lithogenicity and the number of NO synthase immunopositive gastric epithelial cells. The clinical, biochemical and morphologic analyses showed that the application of Hepabene for treating patients with chronic acalculous cholecystitis produces a clinical and biochemical remission in a shorter term. Bile lithogenicity decreases; the quantitative characteristic of NO synthase immunopositive gastric epithelial cells normalizes. The study results make it possible to recommend Hepabene as a highly efficient drug for treating patients with chronic acalculous cholecystitis.
Osadchuk
M A
MA
Kon'kov
A V
AV
Lipatov
T E
TE
D042101:Acalculous Cholecystitis / Q000188:drug therapy / Q000201:enzymology* / Q000473:pathology; D000328:Adult; D000975:Antioxidants / Q000627:therapeutic use; D002908:Chronic Disease; D016099:Endoscopy, Gastrointestinal; D005260:Female; D005753:Gastric Mucosa / Q000201:enzymology*; D006801:Humans; D008297:Male; D019001:Nitric Oxide Synthase / Q000032:analysis* / Q000276:immunology; D012838:Silymarin / Q000627:therapeutic use; D013270:Stomach / Q000473:pathology; D016896:Treatment Outcome
D000975:Antioxidants; D012838:Silymarin; D019001:Nitric Oxide Synthase